Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (abre una nueva ventana)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Fuente‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indexado en‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (abre una nueva ventana)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (abre una nueva ventana)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Fuente‎: Lancet 2018;391(10116):125-32.

Indexado en‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (abre una nueva ventana)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (abre una nueva ventana)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Fuente‎: Am J Perinatol 2013;30(5):407-13.

Indexado en‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (abre una nueva ventana)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (abre una nueva ventana)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Fuente‎: Am J Perinatol 2011;28(3):233-40.

Indexado en‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (abre una nueva ventana)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (abre una nueva ventana)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Fuente‎: Lancet 2017;389(10084):2105-16.

Indexado en‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (abre una nueva ventana)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (abre una nueva ventana)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Fuente‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indexado en‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (abre una nueva ventana)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (abre una nueva ventana)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Fuente‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indexado en‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (abre una nueva ventana)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (abre una nueva ventana)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Fuente‎: Obstet Gynecol 2007;110(6):1270-8.

Indexado en‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (abre una nueva ventana)

The use of recombinant activated FVII in postpartum hemorrhage. (abre una nueva ventana)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Fuente‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indexado en‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (abre una nueva ventana)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (abre una nueva ventana)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Fuente‎: J Perinat Med 2011;40(1):43-9.

Indexado en‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (abre una nueva ventana)

Postpartum hemorrhage: when uterotonics and sutures fail. (abre una nueva ventana)

James AH, McLintock C, Lockhart E.

Fuente‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indexado en‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (abre una nueva ventana)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (abre una nueva ventana)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Fuente‎: Int J Hematol 2012;95(1):57-63.

Indexado en‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (abre una nueva ventana)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (abre una nueva ventana)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Fuente‎: J Thromb Haemost 2015;13(4):520-9.

Indexado en‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (abre una nueva ventana)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (abre una nueva ventana)

Lim Y, Loo CC, Chia V, Fun W.

Fuente‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indexado en‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (abre una nueva ventana)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (abre una nueva ventana)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Fuente‎: Br J Haematol 2001;114(1):174-6.

Indexado en‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (abre una nueva ventana)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (abre una nueva ventana)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Fuente‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indexado en‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (abre una nueva ventana)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (abre una nueva ventana)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Fuente‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indexado en‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (abre una nueva ventana)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (abre una nueva ventana)

Pepas LP, Arif-Adib M, Kadir RA.

Fuente‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indexado en‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (abre una nueva ventana)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (abre una nueva ventana)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Fuente‎: Anesth Analg 2009;109(6):1908-15.

Indexado en‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (abre una nueva ventana)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (abre una nueva ventana)

Prosper SC, Goudge CS, Lupo VR.

Fuente‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indexado en‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (abre una nueva ventana)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (abre una nueva ventana)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Fuente‎: Transfus Med 2012;22(5):344-9.

Indexado en‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (abre una nueva ventana)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (abre una nueva ventana)

Bell SF, Rayment R, Collins PW, Collis RE.

Fuente‎: Int J Obstet Anesth 2010;19(2):218-23.

Indexado en‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (abre una nueva ventana)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (abre una nueva ventana)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Fuente‎: Br J Anaesth 2012;108(6):984-9.

Indexado en‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (abre una nueva ventana)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (abre una nueva ventana)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Fuente‎: J Nippon Med Sch 2014;81(2):94-6.

Indexado en‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (abre una nueva ventana)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (abre una nueva ventana)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Fuente‎: Haemophilia 2012;18(1):25-33.

Indexado en‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (abre una nueva ventana)

Tisseel for management of traumatic postpartum haemorrhage. (abre una nueva ventana)

Dhulkotia JS, Alazzam M, Galimberti A.

Fuente‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indexado en‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (abre una nueva ventana)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (abre una nueva ventana)

Moriarty KT, Premila S, Bulmer PJ.

Fuente‎: BJOG 2008;115(6):793-5.

Indexado en‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (abre una nueva ventana)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (abre una nueva ventana)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Fuente‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indexado en‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (abre una nueva ventana)

Fibrin sealant for management of complicated obstetric lacerations. (abre una nueva ventana)

Whiteside JL, Asif RB, Novello RJ.

Fuente‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indexado en‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (abre una nueva ventana)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (abre una nueva ventana)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Fuente‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Indexado en‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (abre una nueva ventana)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (abre una nueva ventana)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Fuente‎: Int J Obstet Anesth 2011;20(4):293-8.

Indexado en‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (abre una nueva ventana)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (abre una nueva ventana)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Fuente‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indexado en‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (abre una nueva ventana)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (abre una nueva ventana)

Karlsson O, Jeppsson A, Hellgren M.

Fuente‎: Int J Obstet Anesth 2014;23(1):10-7.

Indexado en‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (abre una nueva ventana)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (abre una nueva ventana)

Levy JH, Welsby I, Goodnough LT.

Fuente‎: Transfusion 2014;54(5):1389-405.

Indexado en‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (abre una nueva ventana)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (abre una nueva ventana)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Fuente‎: Int J Obstet Anesth 2015;24(2):174-9.

Indexado en‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (abre una nueva ventana)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (abre una nueva ventana)

Solomon C, Collis RE, Collins PW.

Fuente‎: Br J Anaesth 2012;109(6):851-63.

Indexado en‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (abre una nueva ventana)